1 | Pozelimab | [1] Pozelimab Pozelimab (Pozelimab) | [1] Pozelimab
Pozelimab
(Pozelimab, Pozelimab-bbfg) 💬
| [1] C5 C5 💬
| [11] Alcoholic liver disease Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬 | [2] 11 11, 62 💬
|
2 | Pozelimab + cemdisiran | [2] Cemdisiran Cemdisiran, Pozelimab (Pozelimab) | [1] Pozelimab
Pozelimab
(Pozelimab, Pozelimab-bbfg) 💬
| [1] C5 C5 💬
| [11] Alcoholic liver disease Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬 | [1] 11 11 💬
|
3 | Pozelimab/cemdisiran | [1] Pozelimab Pozelimab (Pozelimab) | [1] Pozelimab
Pozelimab
(Pozelimab, Pozelimab-bbfg) 💬
| [1] C5 C5 💬
| [11] Alcoholic liver disease Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬 | [1] 15 15 💬
|